Review Article Polyphenols As Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies
Total Page:16
File Type:pdf, Size:1020Kb
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Crossref Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity Volume 2016, Article ID 6475624, 17 pages http://dx.doi.org/10.1155/2016/6475624 Review Article Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies Anna Maria Mileo and Stefania Miccadei Regina Elena National Cancer Institute, 00144 Rome, Italy Correspondence should be addressed to Stefania Miccadei; [email protected] Received 22 May 2015; Accepted 21 July 2015 Academic Editor: Amit Tyagi Copyright © 2016 A. M. Mileo and S. Miccadei. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Cancer onset and progression have been linked to oxidative stress by increasing DNA mutations or inducing DNA damage, genome instability, and cell proliferation and therefore antioxidant agents could interfere with carcinogenesis. It is well known that conventional radio-/chemotherapies influence tumour outcome through ROS modulation. Since these antitumour treatments have important side effects, the challenge is to develop new anticancer therapeutic strategies more effective and less toxic for patients. To this purpose, many natural polyphenols have emerged as very promising anticancer bioactive compounds. Beside their well-known antioxidant activities, several polyphenols target epigenetic processes involved in cancer development through the modulation of oxidative stress. An alternative strategy to the cytotoxic treatment is an approach leading to cytostasis through the induction of therapy-induced senescence. Many anticancer polyphenols cause cellular growth arrest through the induction of a ROS-dependent premature senescence and are considered promising antitumour therapeutic tools. Furthermore, one of the most innovative and interesting topics is the evaluation of efficacy of prooxidant therapies on cancer stem cells (CSCs). Several ROS inducers-polyphenols can impact CSCs metabolisms and self-renewal related pathways. Natural polyphenol roles, mainly in chemoprevention and cancer therapies, are described and discussed in the light of the current literature data. 1. Introduction data in literature, suggest that the antioxidant properties of the phenolic compounds may not fully account for their Many epidemiological studies suggest that diet particularly chemopreventive effects [10]. Emerging evidence indicates rich in fruits and vegetables have cancer preventive properties that these polyphenols may also behave as prooxidants to [1–3]. The beneficial effects of diet are attributable, at least in initiate a reactive oxygen species mediated cellular DNA part,topolyphenolswhichhaveantitumouractivitiesbothin breakage and consequent cell death [11]. It has been reported animal models and in humans [4, 5]. thatsuchaprooxidantmechanismisaresultofredox-active During the past few decades the growing interest in natural polyphenols has contributed to understanding these microenvironment in cancer cells due to elevated levels in compounds in terms of their chemical and biological func- copper [12]. Copper is an important redox-active metal ion tions and beneficial effects on human health [6, 7]. With present in chromatin, closely associated with DNA bases the advent of cellular, molecular experimental systems, and can be mobilized by metal chelating agents. Several and transgenic/knockout mice models, relevant advances studies have established that serum, tissue, and cellular inunderstandingthemechanismsinvolvedintheaction copper levels in cancer patients are significantly elevated. of polyphenols have been achieved. Most of the beneficial Given that aberrant redox system is frequently observed in effects of natural polyphenols are considered to reflect their many tumour cells [13], it was hypothesized that polyphenols ability to scavenge-free radicals endogenously generated [8] may selectively affect tumour cells behaviour based on their or formed by radiation and xenobiotics [9]. However, some differential redox status [12]. 2 Oxidative Medicine and Cellular Longevity The protective mechanisms that block the initiation of prevented and some of the most common cancers such as carcinogenesis can be defined as chemoprevention, a concept breast, colorectal, and cervical cancer are curable if treated that was originally introduced by Wattenberg [14]. Interest- promptly. Among many factors that cause cancer, oxidative ingly, natural polyphenols could induce apoptotic cell death stress is one of the most important and well-studied event in preneoplastic or neoplastic cells through various growth that gives rise to the conditions leading to tumour onset and inhibitory mechanisms as the activation of cytochrome c progression [29]. andcaspases,thearrestofcellcycle,andthemodulationof It has been demonstrated that continuous inflammation signalling pathways (NF-B, JAK/STAT) which result in the mayleadtoapreneoplasticsituation[30–32].Inchronically inhibition of tumour progression [15, 16]. inflamed cells, the secretion of a large amount of reactive Research on the anticancer activities of dietary polyphe- oxygen/nitrogen species (ROS/RNS) recruits more activated nols, identified new antitumour molecules that can be used immune cells, which leads to the amplification of dysregu- in cancer prevention and treatment, both alone and in lated processes and eventually to a preneoplastic condition. If combination with current chemotherapy/radiotherapy [17– the amount of cellular ROS/RNS produced is high enough to 19]. overcome endogenous antioxidant response, an irreversible Cellular senescence is a physiological process of irre- oxidative damage to nucleic acids, lipids, and proteins may versible cell-cycle arrest that contributes to various physio- cause genetic and/or epigenetic alterations leading to the logical and pathological processes of aging [20]. Replicative dysregulation of oncogenes and tumour suppressor genes. senescence (RS) is associated with telomere erosion after Hence, the oxidative stress and chronic inflammation pro- repeated cell divisions, whereas stress-induced premature cesses are tightly coupled and the failure to block these senescence (SIPS) is a telomere-independent process and processes could result in genetic/epigenetic changes that occurs in response to aberrant oncogenic signalling, oxidative drive the initiation of carcinogenesis [33]. Furthermore, stress, and DNA damage. Although senescent cells have several studies have shown that oxidative stress affects several irreversibly lost their capacity for cell division, they are viable signalling pathways associated with cell proliferation [34]. and remain metabolically active [21, 22]. Amongthem,theepidermalgrowthfactorreceptorsignalling Induction of cellular senescence can be considered a pathway (EGFR) can be mentioned and key signalling pro- relevant mechanism of tumour suppression. The concept of teins, such as the nuclear factor erythroid 2-related factor prosenescence therapy has emerged over the past few years 2 (NRF2), Ras/Raf, the mitogen activated protein kinases as a novel therapeutic approach to treat cancers. Emerging (MAPKs) ERK1/2, and MEK, phosphatidyl inositol 3-kinase evidence has demonstrated that therapy-induced senescence (PI3K),phospholipaseC,andproteinkinaseCareaffectedby (TIS)isacriticalmechanismthroughwhichmanyanticancer oxidative stress [35–37]. Moreover, ROS alter the expression drugs inhibit tumour progression [23]. TIS may be viewed of the p53 suppressor gene that is a key factor in apoptosis. either as an independent approach to treat cancer cells or as a Thus, oxidative stress causes changes in gene expression, cell combined strategy with conventional chemo-/radiotherapy. proliferation, and apoptosis and plays a significant role in In a neoadjuvant setting, prosenescence therapy could be tumour initiation and progression [37–40]. used with traditional treatments in order to reduce tumour Intriguingly, it is believed that, on the one hand, ROS mass before surgery. Furthermore, the engagement of prose- contribute to the carcinogenesis, but, on the other hand, nescence as an adjuvant therapy could be helpful in reducing excessive amounts of ROS may act as cellular toxicants which the statistical risk of cancer relapse. lead to cancer cell growth arrest, apoptosis, or necrosis [41] Epigenetic alterations, such as DNA methylation, histone (Figure 1). It is speculated that the malignant cells which acetylation level, and gene expression miRNA-regulated can- are under increased level of oxidative stress would be more cer stem cells biology, and induction of premature senescence vulnerable to further ROS attack [42]. in tumour cells have been identified as relevant anticancer The evaluation of tissue redox status has great diagnostic features of many dietary polyphenolic compounds [24– potential in oncology. There are studies showing that low 28]. Increasing data from both cancer epidemiology and antioxidant status and increased oxidative stress levels are experimental attempts support the bright future of polyphe- detected in cancer patients, even before oncology treatment nols as epigenetic modulators, prosenescence inducers, and starts [43]. Moreover, the redox status has a prognostic rel- cancer stem cells metabolism regulators in new anticancer evance for cancer therapy and could significantly